Rethinking Life Sciences

Rethinking Life Sciences

Read Rethinking Life Sciences to find out the latest news and trends from across the pharmaceutical industry.

Partner and Global Chair, Life Sciences

KPMG LLP (UK)

Contact

Also on KPMG.com

Welcome to Rethinking Life Sciences

The highlight of this issue is our video interview with Clare Cutler, VP Oncology, Global Marketing at AbbVie shares her views on the challenges of combination treatments and the implications of therapy pricing. We also uncover the key trends in pharmaceuticals with some leading lights in KPMG’s Exceptional Women in Life Sciences programme

Latest updates

AbbVie’s Clare Cutler talks oncology with Hilary Thomas
A video interview with Clare Cutler, VP Oncology, at AbbVie discusses modern oncology and pursuing better patient outcomes. 


Is it time to shift form price-per-pill to charging for outcomes?
Payers need big savings and R&D is costly. Is it time to shift from price-per-pill to charging for outcomes? 


Patient capital – why user focus is a defining trend for life sciences  Participants in our Exceptional Women in Life Sciences programme share why they think user focus is a defining trend for the sector.


Roadmap for big data beyond the hype – and how firms can build new capabilities
Our roadmap for big data beyond the hype – and how firms can build new capabilities

 

Nutraceticals nation

An emerging category finds its feet. So what’s next for nutraceuticals? 

Life Sciences

Life Sciences

Harness the power of data, technology, strategic and operational experience to enhance your competitive advantage.

Connect with us

 

Request for proposal

 

Submit

KPMG’s new-look website

KPMG’s new-look website